Eterna Therapeutics Inc. (ERNA)

Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion. The post 7 Top-Rated Pharmaceutical Companies to Invest I...

Looking to roll the dice? Consider buying one (or more) of these seven high-risk, but possibly high-return, Reddit stocks.

The biotech is bulking up with a new acquisition.

Brooklyn ImmunoTherapeutics LLC (NYSE: BTX) has executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered mesenchymal stem cell (MSC) therapies using mR...

BTX stock holders will certainly want to brace for volatility. Still, the outlook's bullish as the company pursues its game-changing research.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company's Future During May 25, 2021 Shareholder Update Call

The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) increased by 21.02% today. This is why it happened.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing

BROOKLYN, N.Y.--(BUSINESS WIRE)--Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.

Is change at the C-suite level a good thing for a company? The facts seem to indicate that it's a positive development for BTX stock holders.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics announces the appointment of Christopher Rohde, Ph.D. to the Company's Scientific Advisory Board

Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) has announced a publication in Breast Cancer Research, which demonstrates how multiplex immunofluorescence (mIF) may be used to characterize the immunologic...

This clinical-stage biotech was one of April's brightest stars.

An unknown biotech has turned its early investors into millionaires over the past month. Can it continue its momentum?

The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) increased from over 64% pre-market as it went from $49.80 to over $82 pre-market. This is why it happened.

Brooklyn Immuno Therapeutics Inc. (NYSE: BTX) shares are soaring Friday. The stock is likely continuing its run after the company paid $1 million towards the acquisition of a license for Factor Biosci...

Today, investors in BTX stock appear to be on board in a big way with a major announcement from this hot meme stock and Reddit favorite. The post BTX Stock: The Big News That Has Brooklyn ImmunoTherap...

Shares of Brooklyn ImmunoTherapeutics have surged more than 800% over the past month despite a lack of a major catalyst that could explain the price jump on a fundamental basis.

The stock price of Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) increased by over 30% during intraday trading. This is why it happened.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics Reports Inducement Grants